Share Name Share Symbol Market Type Share ISIN Share Description
Puricore LSE:PURI London Ordinary Share GB00B3XBCR18 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 28.75 0.00 00:00:00
Bid Price Offer Price High Price Low Price Open Price
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 15.89 -6.34 -12.89 14
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 28.75 GBX

Puricore (PURI) Latest News

Real-Time news about Puricore (London Stock Exchange): 0 recent articles
More Puricore News
Puricore Investors    Puricore Takeover Rumours

Puricore (PURI) Discussions and Chat

Puricore Forums and Chat

Date Time Title Posts
07/4/200317:56To Logica2me - Payment complete5

Add a New Thread

Puricore (PURI) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Puricore trades in real-time

Puricore (PURI) Top Chat Posts

love it: mm's must be delaying the trade. 29 March 2016 PuriCore plc ("PuriCore" or the "Company") Director Dealing 29 March 2016 - PuriCore plc (AIM: PURI), announces that, Alex Martin, Chief Executive Officer and Executive Director of the Company, today purchased ordinary shares of 10p each in the share capital of the Company ("Shares"). % of Number Purchase Shareholding issued of Shares price following share Name Date purchased purchased of Shares the purchase capital 29 March Alex Martin 2016 100,000 28p 100,000 0.20%
love it: Nice post Premier1 Company results end of March. Can see Directors buying more if price stays this low.
love it: Had another 10k at 23.9p not sure I would called it a distressed seller but it looks suspicious that it's just one person dropping blocks around 25k today. Guess when they are finished the price will rise again.
danwaits: Riddle, before bigging up any outfit, I think that it's always best to take a peek at past and current performance, especially as early investors in this POS are down almost 95% on their original investments. Two years ago, Puri had two revenue generating divisions; the loss making supermarket business and the endoscopy business which was generating $2m PBT. So, guess which one did they sold? Now they claim growing revenues in the remaining retail side (due mainly to one-off sales of dosing units), but most likely the business remains unprofitable. Solution - "Let's abandon all existing revenue streams and get into the prescription drugs business, which we know absolutely FA about, apart from what some consultant chappies have told us. And let's also recruit some suitable souls to help us spend the last of our share-holders funds as we chase some blue-sky dreams. Gosh, we're brilliant altogether, what spiffingly wonderful money managers we are"
love it: This just might get a bit more interesting. 14 October 2015 PuriCore plc ("PuriCore" or the "Company") Director Dealing 14 October 2015 - PuriCore plc (AIM: PURI), an international company focused on applying its proprietary hypochlorous acid platform technology to unmet needs in human health, announces that, on 14 October 2015, the Director named below notified the Company that he had purchased ordinary shares of 10p each in the share capital of the Company ("Shares"). % of Number Purchase Shareholding issued of Shares price following the share Name Date purchased purchased of Shares purchase capital Daniel Hegglin Non-Executive Director 13 October 2015 500,000 18p 5,909,091 11.79%
danwaits: Because it's not very profitable gfrae, despite the management's best efforts to rectify the problems. Imagine you have on big machine at a central base which churns out gallons of product, which are packaged as RTU sprays, or in HC's which can be diluted as and when a customer requires them. These stable, long life products can be shipped out to the retail company's central distribution warehouse and delivered to each outlying store from there. That is the very model that PURI want for their products. The retailers however, want machines in each store, continuously churning out fresh product at source. This means that PURI must install several machines, often located hundreds of miles apart and service them regularly, whilst also supplying the base chemical product at a much lower margin than the pre-packaged products. The customer is not always right, especially when they expect the supplier to continue committing slow hara-kiri. Today's RNS suggests that the big customers are still dictating terms, despite the company's extreme efforts in the past while to re-transition the business.
gfrae: Dan,why would'nt you invest in PURI if you think the product is so good? Don't you think they'll make any money out of it? G.
danwaits: Whilst the announcement of any new sales contract can only be good news, there's some interesting detail in this morning's RNS. It's obvious that the in-house Sterilox system is not too profitable for PURI, due to the high labour costs involved in servicing the units at a retail outfit's multiple sites. Which is why they announced that the were repositioning the business towards the HC (high concentrate) or RTU (ready-to-use) model. This made perfect sense, however this morning's news informs us that the major retailers are saying "We don't want HC or RTU, we want our own mixing units in-house and if you don't want to give it to us, we'll be on to Ecolab or Diversey like a hot snot". So, PURI are stuck with the busy fools business model, which can only be solved by astute marketeering and logistics management. Me, I LOVE the product and think it has amazing potential, but wouldn't for a minute be tempted to invest in PURI.
fishbournetrader: So the board believe that they can manage the shareholder's money better than the shareholder's can!!! I certainly haven't seen any evidence of this so far. This company is really just a large bank balance with a small loss making business attached. What they will actually do is slowly spend it on lining their own pockets and what we will be left with, if we are lucky, is a slightly larger business making a small profit and a share price of less than 20p.
stylesip: NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO THE SAME WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION PuriCore plc("PuriCore" or the "Company")Proposed Cancellation of Listing on the Official List, Admission to AIMand Notice of General Meeting 7 November 2014 - PuriCore plc (LSE: PURI), a global company focused on safe and effective protection against the spread of infectious pathogens, announces today that the Board is proposing to cancel the listing of the Company's Ordinary Shares on the premium segment of the Official List and their trading on the Main Market and to apply for admission of the Ordinary Shares to trading on AIM. The Board believes key advantages to be gained by this move include that a listing on AIM: · Should afford the most appropriate exchange for trading in the Company's Shares by providing a market and environment more suited to the Company's current size and to achieving its corporate objectives· May increase the appeal of the Company to new retail investors while continuing to appeal to institutional investors· Offers greater flexibility to the Company, particularly with regard to corporate transactions· Establishes a more cost-effective platform on which to maintain the Company's publicly traded status· Should reduce time and cost of compliance whilst maintaining appropriate disclosure and corporate governance practices Michael Ashton, Chief Executive Officer of PuriCore, commented: "As previously announced, the Company has initiated a strategic and operational review of the business. In parallel with this review, the Board considered how to increase the appeal of the Company to new investors and which was the right platform on which to maintain the Company's publicly traded status. After careful consideration, the Board believes that the proposed move to AIM will afford the most appropriate exchange for trading in the Company's Shares by providing a market and environment more suited to the Company's current size and to achieving the advantages listed above. "The Board has advanced the strategic and operational review and plans to announce further information before the year end." A circular dated, 7 November 2014, (the "Circular"), which contains a Notice convening a General Meeting, to be held at the offices of CMS Cameron McKenna LLP, Mitre House, 160 Aldersgate Street, London EC1A 4DD at 11.00 a.m. on 24 November 2014, will be posted to Shareholders today. The Circular outlines the reasons for the proposed Delisting and Admission and explains why the Board believes such proposals to be in the best interests of the Company and its Shareholders as a whole. At the General Meeting, the Company will seek Shareholder approval for the proposed cancellation of admission to the premium segment of the Official List and to trading on the London Stock Exchange's Main Market for listed securities ("Delisting") and the intention to apply for admission to trading on AIM ("Admission") will be detailed. Extracts from the letter from the Chairman contained within the Circular and the expected timetable of principal events are reproduced below. The Circular will be made available on the Company's website at and shortly will be submitted to the National Storage Mechanism where it will be available at All capitalised and defined terms used in this announcement have the same meanings as set out in the Circular. Additionally, PuriCore is pleased to announce the appointment of N+1 Singer as the Company's financial adviser in connection with the Delisting, which is effective immediately, and as the Company's Nominated Adviser and Broker which is effective on Admission.
Puricore share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210124 01:06:03